Learn about:
1. CMS quality measures.
2. How to capture the data in Practice Fusion.
3. How this data can be used to earn incentive payments through quality reporting programs, including Meaningful Use and PQRS.
New clinical quality measure reporting in Practice Fusion [slides]Practice Fusion
Learn about the new data elements, which quality measures they can be used for, and information on reporting quality measures using Practice Fusion for Meaningful Use, PQRS EHR Reporting, and other quality improvement programs.
Measuring & Monitoring Clinical Quality Measures Using Practice FusionPractice Fusion
Review CMS quality measures, how to capture the data in Practice Fusion, and how this data can be used to earn incentive payments through quality reporting programs, including Meaningful Use and PQRS.
Measuring and Monitoring Clinical Quality Measures in Practice FusionKimberly Hilton
Clinical Quality Measures (CQMs) are used to measure and monitor the quality of care provided in practices. CQMs consist of numerators and denominators that are defined by measure specifications. Practice Fusion supports recording CQM data elements to report on over 25 CQMs across all six National Quality Strategy domains. Providers can record screening results, assessments, and follow-up plans in the patient chart to submit CQM data for quality reporting programs.
Meaningful Use Stage 2 and Health Information Exchange (HIE)MassEHealth
Transformational intent of Meaningful Use (MU) and the increased trend toward interoperability in MU Stage 2 (MU2); MU2 objectives with an HIE component and their MU2 measures; Approaches to achieving the transitions of care; Available public health registries and their current status and submission pathway; How to find a trading partner and best practices to engaging
The medical director is responsible for developing, implementing, and overseeing a facility's robust quality assessment and performance improvement (QAPI) program. This includes establishing a multidisciplinary team to regularly review data, prioritize issues, and take corrective actions to improve patient outcomes and safety. The QAPI program must measure and address various clinical areas at minimum, and compliance is determined by reviewing outcomes, records, and interviewing staff.
New clinical quality measure reporting in Practice Fusion [slides]Practice Fusion
Learn about the new data elements, which quality measures they can be used for, and information on reporting quality measures using Practice Fusion for Meaningful Use, PQRS EHR Reporting, and other quality improvement programs.
Measuring & Monitoring Clinical Quality Measures Using Practice FusionPractice Fusion
Review CMS quality measures, how to capture the data in Practice Fusion, and how this data can be used to earn incentive payments through quality reporting programs, including Meaningful Use and PQRS.
Measuring and Monitoring Clinical Quality Measures in Practice FusionKimberly Hilton
Clinical Quality Measures (CQMs) are used to measure and monitor the quality of care provided in practices. CQMs consist of numerators and denominators that are defined by measure specifications. Practice Fusion supports recording CQM data elements to report on over 25 CQMs across all six National Quality Strategy domains. Providers can record screening results, assessments, and follow-up plans in the patient chart to submit CQM data for quality reporting programs.
Meaningful Use Stage 2 and Health Information Exchange (HIE)MassEHealth
Transformational intent of Meaningful Use (MU) and the increased trend toward interoperability in MU Stage 2 (MU2); MU2 objectives with an HIE component and their MU2 measures; Approaches to achieving the transitions of care; Available public health registries and their current status and submission pathway; How to find a trading partner and best practices to engaging
The medical director is responsible for developing, implementing, and overseeing a facility's robust quality assessment and performance improvement (QAPI) program. This includes establishing a multidisciplinary team to regularly review data, prioritize issues, and take corrective actions to improve patient outcomes and safety. The QAPI program must measure and address various clinical areas at minimum, and compliance is determined by reviewing outcomes, records, and interviewing staff.
Clinical Quality Measures (CQMs) for Meaningful Use & PQRSEmily Richmond
This presentation provides information on reporting clinical quality measures (CQMs) for Meaningful Use and PQRS, while also providing detailed information on the quality measure specifications that Practice Fusion currently supports.
Practice Fusion is a free, web-based, 2014 certified complete ambulatory EHR.
www.practicefusion.com/signup/
Closed Loop Medication Management - A preferred way to go go forward for Prov...CitiusTech
Closed Loop Medication Management (CLMM) system is a fully electronic medication management process that integrates automated and intelligent systems to completely close the inpatient medication management and administration loop, and seamlessly document all the relevant information.
This document provides an overview and summary of quality in healthcare initiatives. It discusses the industry background and shift towards quality and value-based care. It outlines key federal quality programs like CMS Star Ratings and accrediting entities like NCQA. It also summarizes Puerto Rico's quality retention fund and examples of clinical quality measures like breast cancer screening and diabetes management. Finally, it reviews risk adjustment programs in Medicare Advantage, Commercial ACA, and Managed Medicaid.
How to Engage Physicians in Quality/Safety Improvement Using MetricsWellbe
The unsustainable rising cost of medical care is creating financial pressures that will critically alter the way that health care is both paid for and delivered. Limited resources dictate that we become more efficient at providing high quality care. In an effort to provide financial incentive for delivering quality care the Federal government instituted Value Based Purchasing (VBP) and Bundled Payments. In order to maximize reimbursement under these programs, providers of health care must follow to the basic tenants of the quality principles.
Lorraine Hutzler, Associate Director of the Center for Quality and Patient Safety at NYU Hospital for Joint Diseases at the NYU Langone Medical Center, will discuss:
• How to build a quality infrastructure for your orthopedic program
• What quality metrics to measure and how to engage surgeons using them
• Lean and Six Sigma principles to use to accelerate improvement
About the Speaker:
Lorraine100Lorraine Hutzler is the Associate Director of the Center for Quality and Patient Safety at NYU Hospital for Joint Diseases at the NYU Langone Medical Center and a Principal of Labrador Healthcare Consulting. She designed, built and maintains a robust quality infrastructure for the Department of Orthopaedic Surgery. Lorraine has extensive expertise in quality metrics management and reporting as well as Lean and Six Sigma Certification.
This document provides an overview of electronic clinical quality measures (eCQMs) and the transition from manual chart abstraction to electronic reporting of quality measures. It discusses upcoming requirements for eCQM reporting to CMS programs like IQR and the vision for a unified set of electronically specified measures. The document reviews the eCQM reporting process including planning, testing, validation and submission. Challenges and opportunities of eCQM reporting are also addressed.
Observation medicine nursing considerationsmflitcraft
This document provides an overview and outline of topics related to observation medicine and nursing considerations at Ronald Reagan UCLA Medical Center. It discusses UCLA Health System and patient satisfaction scores. The outline covers observation review settings and examples, the business case for observation including data analysis and cost considerations, staffing mix and characteristics, daily operations, and quality metrics. It provides details on Medicare rules and coverage for observation, examples of retrospective data reviews for observation opportunities, and considerations for staffing and managing observation patients.
The document summarizes the key aspects of the American Recovery and Reinvestment Act (ARRA) related to economic stimulus incentives for healthcare providers to adopt electronic medical record (EMR) technology. It outlines the incentive payments available through Medicare and Medicaid programs for providers who can demonstrate meaningful use of certified EMR systems. It also describes the core objectives and clinical quality measures that providers must meet to qualify for the incentive payments. The summary concludes by advising healthcare providers to start researching their EMR options soon to take advantage of the front-loaded incentive payments.
Chronic Care Management (CCM) involves coordinating care between patient visits to improve health outcomes and reduce costs for patients with chronic conditions. Medicare now reimburses providers for CCM services, defined as at least 20 minutes per month of care coordination. To bill for CCM, providers must meet requirements such as developing comprehensive care plans, ensuring 24/7 access to care teams, and using certified EHR technology. CCM has the potential to improve chronic disease management but providers must implement services carefully to comply with Medicare's billing criteria.
The document provides a comparison of quality indicators between the 4th and 3rd editions of the NABH standards. It summarizes the key changes made to various quality indicators for monitoring access to care, care of patients, medication management, infection control, CQI processes, and other areas. For most indicators, the definitions and formulas for calculation remain the same between the editions, while some new indicators were added and the frequency of data collection was standardized in the 4th edition.
This document discusses clinical audits, which systematically review patient care against criteria to improve outcomes. Clinical audits compare current practices to standards to identify any gaps and drive improvements. They have been incorporated worldwide as part of clinical governance efforts since the 1990s. Some key points made include:
- Clinical audits can reduce risks, ensure cost-effectiveness, and improve patient care and outcomes.
- One of the earliest clinical audits was conducted by Florence Nightingale during the Crimean War, which significantly reduced mortality rates.
- Audits ask if standards are being followed correctly, while research asks if the right approach is being taken.
- Successful audits include clear, measurable criteria; objective data collection; analysis
This document discusses electronic clinical quality measures (eCQMs) and the transition to mandatory eCQM reporting. It notes that the 2016 IPPS rule will require hospitals to submit 4 eCQMs beginning in 2016. Additional programs like Joint Commission and Outpatient Quality Reporting are also moving to require eCQMs. The document reviews the eCQM reporting process and considerations for eCQM selection. It provides an example of eCQM reporting for the VTE-3 measure and submission in the QRDA format. Looking ahead, value-based programs and the transition to consolidated quality programs through MACRA are discussed.
Presentation: Spotlight on prescription medicines reformsTGA Australia
An overview of initiatives arising from the Review of Medicines and Medical Devices Regulation relevant to prescription medicines as well as orphan drugs and developments for eCTD and the new MedSearch app.
CMS offers various telehealth solutions including remote patient monitoring devices, software, and clinical support to improve patient outcomes, reduce costs, and prevent hospital readmissions by allowing patients to be monitored at home and addressing health issues before they require a hospital visit. The solutions help hospitals avoid penalties for excessive readmissions and support post-discharge care. CMS also provides programs and services to support telehealth program development and operations.
Impact of innovative therapies on regulation of therapeutic goods - John Sker...TGA Australia
The nature of medicines and medical technologies has changed significantly with the rise of biologics, personalized medicine, and combination products, requiring therapeutic goods regulation to evolve; emerging areas like adaptive licensing, real-world data, and regulatory science will be important for facilitating patient access to innovative therapies while managing risks; regulatory agencies also face challenges in evaluating new technologies quickly and supporting small companies developing novel products.
RQHR developed a strategic approach to improve patient flow based on best practices. Short term initiatives included implementing Allscripts patient flow software, establishing governance structures for patient flow, developing standard work and care planning processes, and leveling demand through surgical targeting. The results were reduced admit no bed numbers, decreased system occupancy and wave times, and closed hallway beds. RQHR's framework was adopted provincially to improve ED waits and flow.
TGA presentation: MMDR Consultation - Strengthening monitoring of medicines i...TGA Australia
The document outlines new and enhanced pharmacovigilance activities being implemented by the TGA to strengthen post-market monitoring of medicines in Australia. Key changes include establishing a Pharmacovigilance Inspections Program, implementing a Black Triangle Scheme, monitoring compliance with Risk Management Plans, developing a new Adverse Events Management System, reformatting Product Information, and increasing collaboration with overseas regulators and use of advanced data analytics. The changes aim to ensure the ongoing safety of medicines on the Australian market through improved monitoring and risk mitigation strategies.
This document outlines the clinical audit policy and strategy for Response Med. It discusses statutory requirements that mandate regular clinical audits to assess quality and ensure patient safety. The purposes are to define a framework for clinical audits and clarify roles and responsibilities. The outcomes aim to provide evidence of a robust audit program, improvements based on audit findings, and adherence to best practices. The procedures describe developing an annual audit plan, conducting audits, and monitoring completion of the plan.
Overview of Stage 2 Clinical Quality Measures for the Medicare and Medicaid E...Brian Ahier
Session provides in-depth overview of clinical quality measures included in the final rule for Stage 2 of Meaningful Use for the EHR Incentive Programs for eligible professionals. Details provided on the measures, the recommended core set for reporting purposes, and the upcoming release of the 2014 electronic specifications for the EHR Incentive Programs.
This document discusses the requirements for Meaningful Use Stage 2. It outlines the core and menu objectives including clinical quality measures, electronic prescribing, health information exchange, patient electronic access, and secure messaging. It provides guidance on exclusions and gives workflows within Practice Fusion for how to meet each objective. Key requirements include reporting 9 clinical quality measures covering 3 domains, using computerized physician order entry for 60% of medications and incorporating structured lab results.
Clinical Quality Measures (CQMs) for Meaningful Use & PQRSEmily Richmond
This presentation provides information on reporting clinical quality measures (CQMs) for Meaningful Use and PQRS, while also providing detailed information on the quality measure specifications that Practice Fusion currently supports.
Practice Fusion is a free, web-based, 2014 certified complete ambulatory EHR.
www.practicefusion.com/signup/
Closed Loop Medication Management - A preferred way to go go forward for Prov...CitiusTech
Closed Loop Medication Management (CLMM) system is a fully electronic medication management process that integrates automated and intelligent systems to completely close the inpatient medication management and administration loop, and seamlessly document all the relevant information.
This document provides an overview and summary of quality in healthcare initiatives. It discusses the industry background and shift towards quality and value-based care. It outlines key federal quality programs like CMS Star Ratings and accrediting entities like NCQA. It also summarizes Puerto Rico's quality retention fund and examples of clinical quality measures like breast cancer screening and diabetes management. Finally, it reviews risk adjustment programs in Medicare Advantage, Commercial ACA, and Managed Medicaid.
How to Engage Physicians in Quality/Safety Improvement Using MetricsWellbe
The unsustainable rising cost of medical care is creating financial pressures that will critically alter the way that health care is both paid for and delivered. Limited resources dictate that we become more efficient at providing high quality care. In an effort to provide financial incentive for delivering quality care the Federal government instituted Value Based Purchasing (VBP) and Bundled Payments. In order to maximize reimbursement under these programs, providers of health care must follow to the basic tenants of the quality principles.
Lorraine Hutzler, Associate Director of the Center for Quality and Patient Safety at NYU Hospital for Joint Diseases at the NYU Langone Medical Center, will discuss:
• How to build a quality infrastructure for your orthopedic program
• What quality metrics to measure and how to engage surgeons using them
• Lean and Six Sigma principles to use to accelerate improvement
About the Speaker:
Lorraine100Lorraine Hutzler is the Associate Director of the Center for Quality and Patient Safety at NYU Hospital for Joint Diseases at the NYU Langone Medical Center and a Principal of Labrador Healthcare Consulting. She designed, built and maintains a robust quality infrastructure for the Department of Orthopaedic Surgery. Lorraine has extensive expertise in quality metrics management and reporting as well as Lean and Six Sigma Certification.
This document provides an overview of electronic clinical quality measures (eCQMs) and the transition from manual chart abstraction to electronic reporting of quality measures. It discusses upcoming requirements for eCQM reporting to CMS programs like IQR and the vision for a unified set of electronically specified measures. The document reviews the eCQM reporting process including planning, testing, validation and submission. Challenges and opportunities of eCQM reporting are also addressed.
Observation medicine nursing considerationsmflitcraft
This document provides an overview and outline of topics related to observation medicine and nursing considerations at Ronald Reagan UCLA Medical Center. It discusses UCLA Health System and patient satisfaction scores. The outline covers observation review settings and examples, the business case for observation including data analysis and cost considerations, staffing mix and characteristics, daily operations, and quality metrics. It provides details on Medicare rules and coverage for observation, examples of retrospective data reviews for observation opportunities, and considerations for staffing and managing observation patients.
The document summarizes the key aspects of the American Recovery and Reinvestment Act (ARRA) related to economic stimulus incentives for healthcare providers to adopt electronic medical record (EMR) technology. It outlines the incentive payments available through Medicare and Medicaid programs for providers who can demonstrate meaningful use of certified EMR systems. It also describes the core objectives and clinical quality measures that providers must meet to qualify for the incentive payments. The summary concludes by advising healthcare providers to start researching their EMR options soon to take advantage of the front-loaded incentive payments.
Chronic Care Management (CCM) involves coordinating care between patient visits to improve health outcomes and reduce costs for patients with chronic conditions. Medicare now reimburses providers for CCM services, defined as at least 20 minutes per month of care coordination. To bill for CCM, providers must meet requirements such as developing comprehensive care plans, ensuring 24/7 access to care teams, and using certified EHR technology. CCM has the potential to improve chronic disease management but providers must implement services carefully to comply with Medicare's billing criteria.
The document provides a comparison of quality indicators between the 4th and 3rd editions of the NABH standards. It summarizes the key changes made to various quality indicators for monitoring access to care, care of patients, medication management, infection control, CQI processes, and other areas. For most indicators, the definitions and formulas for calculation remain the same between the editions, while some new indicators were added and the frequency of data collection was standardized in the 4th edition.
This document discusses clinical audits, which systematically review patient care against criteria to improve outcomes. Clinical audits compare current practices to standards to identify any gaps and drive improvements. They have been incorporated worldwide as part of clinical governance efforts since the 1990s. Some key points made include:
- Clinical audits can reduce risks, ensure cost-effectiveness, and improve patient care and outcomes.
- One of the earliest clinical audits was conducted by Florence Nightingale during the Crimean War, which significantly reduced mortality rates.
- Audits ask if standards are being followed correctly, while research asks if the right approach is being taken.
- Successful audits include clear, measurable criteria; objective data collection; analysis
This document discusses electronic clinical quality measures (eCQMs) and the transition to mandatory eCQM reporting. It notes that the 2016 IPPS rule will require hospitals to submit 4 eCQMs beginning in 2016. Additional programs like Joint Commission and Outpatient Quality Reporting are also moving to require eCQMs. The document reviews the eCQM reporting process and considerations for eCQM selection. It provides an example of eCQM reporting for the VTE-3 measure and submission in the QRDA format. Looking ahead, value-based programs and the transition to consolidated quality programs through MACRA are discussed.
Presentation: Spotlight on prescription medicines reformsTGA Australia
An overview of initiatives arising from the Review of Medicines and Medical Devices Regulation relevant to prescription medicines as well as orphan drugs and developments for eCTD and the new MedSearch app.
CMS offers various telehealth solutions including remote patient monitoring devices, software, and clinical support to improve patient outcomes, reduce costs, and prevent hospital readmissions by allowing patients to be monitored at home and addressing health issues before they require a hospital visit. The solutions help hospitals avoid penalties for excessive readmissions and support post-discharge care. CMS also provides programs and services to support telehealth program development and operations.
Impact of innovative therapies on regulation of therapeutic goods - John Sker...TGA Australia
The nature of medicines and medical technologies has changed significantly with the rise of biologics, personalized medicine, and combination products, requiring therapeutic goods regulation to evolve; emerging areas like adaptive licensing, real-world data, and regulatory science will be important for facilitating patient access to innovative therapies while managing risks; regulatory agencies also face challenges in evaluating new technologies quickly and supporting small companies developing novel products.
RQHR developed a strategic approach to improve patient flow based on best practices. Short term initiatives included implementing Allscripts patient flow software, establishing governance structures for patient flow, developing standard work and care planning processes, and leveling demand through surgical targeting. The results were reduced admit no bed numbers, decreased system occupancy and wave times, and closed hallway beds. RQHR's framework was adopted provincially to improve ED waits and flow.
TGA presentation: MMDR Consultation - Strengthening monitoring of medicines i...TGA Australia
The document outlines new and enhanced pharmacovigilance activities being implemented by the TGA to strengthen post-market monitoring of medicines in Australia. Key changes include establishing a Pharmacovigilance Inspections Program, implementing a Black Triangle Scheme, monitoring compliance with Risk Management Plans, developing a new Adverse Events Management System, reformatting Product Information, and increasing collaboration with overseas regulators and use of advanced data analytics. The changes aim to ensure the ongoing safety of medicines on the Australian market through improved monitoring and risk mitigation strategies.
This document outlines the clinical audit policy and strategy for Response Med. It discusses statutory requirements that mandate regular clinical audits to assess quality and ensure patient safety. The purposes are to define a framework for clinical audits and clarify roles and responsibilities. The outcomes aim to provide evidence of a robust audit program, improvements based on audit findings, and adherence to best practices. The procedures describe developing an annual audit plan, conducting audits, and monitoring completion of the plan.
Overview of Stage 2 Clinical Quality Measures for the Medicare and Medicaid E...Brian Ahier
Session provides in-depth overview of clinical quality measures included in the final rule for Stage 2 of Meaningful Use for the EHR Incentive Programs for eligible professionals. Details provided on the measures, the recommended core set for reporting purposes, and the upcoming release of the 2014 electronic specifications for the EHR Incentive Programs.
This document discusses the requirements for Meaningful Use Stage 2. It outlines the core and menu objectives including clinical quality measures, electronic prescribing, health information exchange, patient electronic access, and secure messaging. It provides guidance on exclusions and gives workflows within Practice Fusion for how to meet each objective. Key requirements include reporting 9 clinical quality measures covering 3 domains, using computerized physician order entry for 60% of medications and incorporating structured lab results.
The State of Clinical Outsourcing: Managing Risk in Outsourced Clinical Trials
Interactive Discussion Based on Data from Avoca’s 2013 Industry Research DIA Forum
June 24, 2013
Pharma-CRO Relationships Managing Risk A Lawyer\'s Viewalbinpaul
The document discusses sponsor-CRO relationships and managing risks when outsourcing clinical trials to contract research organizations (CROs). It defines CROs and site management organizations (SMOs) and their roles. It also discusses selecting CROs, establishing metrics to measure performance, managing personnel changes and communications, and proactively avoiding and resolving disputes. The key aspects are selecting the right CRO based on expertise and compatibility, establishing metrics for accountability and continuous improvement, and clear communications and dispute resolution processes to facilitate the relationship.
CRO/Vendor oversight should support sponsor regulatory requirements and cost containment.Quality Management in clinical operations are Centralized Monitoring, Study Quality Metrics and CRO Oversight.
This ICU RN resume sample provides an overview of a registered nurse with 5 years of experience in an intensive care unit. The resume highlights clinical skills in ventilator management, hemodynamic monitoring, and emergency response. Relevant experience includes care of patients with multiple organ dysfunction, trauma, and postoperative complications.
2016 Resume of Tiffany Tindall RN 727.804.4466Tiffany Tindall
Over 24 years of customer care excellence experience working with; Critical Care/ER & Home Health Nursing~Sales & Marketing Liaison~Nsg IT Cerner-'Train the Trainer' ~Education/Training Development ~Community Outreach Programs/Education ~Humana/Care Plus Case Management~DNV & JCHAHO Accreditation~Magnet Council~Team Building~HCAPS Survery. See resume for more!
Deborah M. Brandenburg is a registered nurse with over 30 years of experience in medical/surgical floor nursing and intensive care units. She has extensive experience in patient assessment, planning, implementation, and evaluation. She is certified in ICD-9 and ICD-10 medical coding through AAPC.
Rowelyn Tenebro Gesta is seeking a position as a nurse where she can utilize her skills in human relations, communication, leadership, and training. She has over 7 years of experience as a nurse in Saudi Arabia and the UAE, working in polyclinics, schools, and home visits. Her experience includes assessing patients, developing care plans, administering medications, and providing first aid. She is proficient in computer software, communicates well both orally and in writing, and is able to work independently or as part of a team. Gesta earned a Bachelor of Science in Nursing in 2008 and is fluent in English, Arabic, and Filipino.
Ramona Wendt is an experienced RN seeking a permanent position. She has 20 years of experience working in acute care hospital settings, with a preference for cardiac nursing at the intensive care level. Her experience includes working in telemetry units, ICUs, step-down units, and she is competent in caring for patients on ventilators and with tracheostomies. She is obtaining her BSN and certifications to further develop her skills in critical thinking and nursing abilities.
Dana O'Harold is an experienced registered nurse seeking an ICU position. She has over 16 years of experience in PACU/surgery/ICU and is skilled in areas like patient care, leadership, education, and advocacy. Her professional history includes positions in Texas, Louisiana, Ohio, North Carolina, Vermont, and Florida, allowing her to gain diverse experience in trauma ICUs and other units. She is accomplished, caring, and dedicated to superior patient care.
The document is a resume for N. Juliette Thompson, an RN with over 7 years of ICU experience and 18 months of hospice case management experience, who is seeking a new nursing position and provides details of her relevant work history and qualifications, including experience in wound care, palliative care, patient advocacy, and management roles.
Carly Weddle is an ICU nurse with over 10 years of nursing experience in various healthcare settings including hospitals, mental health facilities, and long-term care. She has clinical expertise in caring for diverse patient populations across the lifespan. Weddle is known among her peers as a hard worker, effective communicator, and mentor. She is pursuing her BSN and maintains certifications in medical-surgical nursing and critical care. Weddle has received numerous awards for her work at the VA hospital where she currently serves on several committees focused on clinical practice, restraint policies, and mentoring students.
The document provides a summary of Mae Temporal Ramirez's professional experience as an ICU nurse. It outlines her work history in ICU units in Dubai, the UK, and the Philippines from 1999 to present. Her experience includes caring for critically ill patients, performing procedures, monitoring various medical equipment, administering medications, and collaborating with medical teams. She is experienced in caring for patients with conditions such as respiratory failure, organ failure, and post-operative care.
This presentation attempts to answer one of the most pressing questions facing the software industry: how to develop and maintain high quality software.
This Presentation is about why CRO/Vendor oversight should support sponsor regulatory requirements and cost containment.
Topics covered:
1.Importance of CRO/Vendor oversight in clinical trial management.
2. Identify the ways to integrate a risk-based approaches to CRO/Vendor oversight.
3. Developing a CRO/Vendor oversight plan with appropriate KPIs/metrics to be measured.
4. Use of tools and technology for accurate and timely reporting.
Regina Cole has over 20 years of experience in healthcare IT, clinical leadership, and nursing education. She currently works as an independent consultant, providing strategic guidance to healthcare organizations on clinical informatics best practices. She also holds adjunct faculty positions where she teaches courses in health informatics. Cole has extensive expertise implementing and optimizing electronic health records and other clinical systems to improve patient outcomes.
Steve Stephens Epic Go Live and Credentialed Trainer ResumeSteve J Stephens
Steve Stephens has over 9 years of experience as a senior Epic trainer specializing in ADT, Cadence, Prelude, Ambulatory, and Referrals applications. He has a master's degree in public administration and has instructed over 4800 hours of Epic end user training across multiple large health systems. His experience includes 14 go-lives and he is currently seeking a senior credentialed Epic trainer position.
The document discusses clinical quality measures (CQMs) and reporting CQMs through Practice Fusion to meet requirements for programs like Meaningful Use and PQRS. It explains that providers are increasingly evaluated on quality and outcomes, describes key quality programs and their CQM reporting requirements, and provides guidance on selecting applicable CQMs and the reporting process through Practice Fusion.
Using Practice Fusion for PQRS EHR Reporting in 2014Practice Fusion
This presentation is an overview of PQRS requirements in 2014, requirements for PQRS EHR reporting, and measure selection and EHR reporting applicability. The presentation will also give a deep dive into using Practice Fusion for PQRS reporting.
This document provides information on surgical audit and clinical research. It defines clinical audit as a quality improvement process that systematically reviews care against criteria to implement change and improve outcomes. Surgical audit similarly analyzes surgical quality and care against standards to improve practice. Audits identify if standards are met and research is used in practice, help reduce risk, and improve patient care. They follow the clinical audit cycle of choosing topics, collecting data, analyzing results against criteria, improving care, and re-auditing. Research aims to generate new knowledge by testing treatments or regimens with study design and analysis. It asks different questions than audits and requires identifying topics, designing projects, analyzing data, and publishing findings.
This document discusses fundamentals of quality in healthcare. It defines key terms like quality assurance, quality of care, and factors driving attention to quality like limited resources and patient demands. It describes Donabedian's framework for assessing quality, which looks at structure, process and outcomes. Achieving quality requires accessible, efficient and acceptable services. Ensuring quality involves continuous quality improvement approaches like plan-do-check-act cycles and evidence-based medicine. The goal is to provide high quality care through ongoing evaluation and improvement.
This document discusses fundamentals of quality in healthcare. It defines key terms like quality assurance, total quality management, and continuous quality improvement. It explains that quality can be assessed based on structure, process, and outcomes. Structure looks at the environment where care is provided. Process examines the care provided by practitioners. Outcomes assess the benefits achieved by patients. Achieving quality requires accessible, efficient, and acceptable services based on current knowledge. Continuous efforts are needed to monitor, assess, and improve healthcare quality.
This document discusses clinical audit, which seeks to improve patient care through systematic review of care against criteria and implementing changes where needed. It defines audit and outlines the audit cycle of selecting a topic, identifying standards, collecting data on performance, implementing changes if needed, and monitoring further to ensure improvement. The document provides examples of what can be audited, such as structure, processes of care, or outcomes. It emphasizes that audit criteria should be evidence-based and measurable. The goal of audit is to continuously improve quality of care.
Nephrology leadership program 5 quality control and improvment in dialysis a...Ala Ali
This document discusses quality in nephrology leadership and management. It defines quality and outlines three categories of quality defects: underuse, overuse, and misuse of medical practices. The Donabedian model of quality is introduced, which examines structure, process, and outcomes of healthcare delivery. Quality assurance, quality control, quality assessment, and performance improvement are distinguished. The Plan-Do-Study-Act cycle for quality improvement is explained. An interdisciplinary team approach and various quality metrics and programs for end-stage renal disease are outlined. Challenges of quality incentive programs are also noted.
Dr Ayman Ewies - Clinical audit made easyAymanEwies
This document provides an overview of how to conduct a clinical audit. It defines clinical audit as a process used by healthcare professionals to systematically review, evaluate and improve patient care. The document outlines the key components of an audit, including choosing a topic, selecting standards, planning methodology, collecting data, analyzing results, and implementing changes. It emphasizes that the goal of audit is to compare current practices to standards in order to enhance quality of care and patient outcomes.
The clinicalaudit.ie website is dedicated to improving patient care standards by providing information for anyone interested in clinical audit. Please download a copy of this PDF for offline viewing.
Cadth symposium 2015 d3 pro presentation apr 2015 - for debCADTH Symposium
This document summarizes a presentation on implementing patient reported outcomes (PROs) to improve patient-centered care. It discusses collecting PRO data through distress screening tools and patient satisfaction surveys, analyzing the data, and using it to select and evaluate quality improvement initiatives. PROs are outcomes that patients report on issues like symptoms, experience of care, and quality of life. The presentation outlines the benefits of PROs, Saskatchewan Cancer Agency's implementation including two PRO tools and progress to date, and lessons learned around using a phased approach and technology to gather and apply PRO evidence to enhance care.
Top seven healthcare outcome measures of healthJosephMtonga1
The seven healthcare outcome measures are meant to understand the quality of health systems and how they could be measured and how quality care could be provided to clients.
This document discusses key concepts of quality in healthcare including definitions, dimensions, and frameworks. It defines quality as meeting expectations and conforming to standards. The dimensions of quality - effectiveness, efficiency, safety, patient-centeredness, timeliness, and more - must be achieved to provide the right care. Quality is measured using a structure-process-outcome framework where structure leads to processes which lead to outcomes. Total quality management is presented as the latest approach focusing on continuous improvement, customer satisfaction, and organizational commitment to quality.
This document discusses clinical audits in anaesthesia. It defines clinical audits as quality improvement processes that systematically review care against criteria to improve outcomes. The document outlines the history of audits dating back to Florence Nightingale. It describes different types of audits including clinical, critical event, outcome, training, and survey audits. The audit cycle is also explained as preparing criteria, measuring performance, implementing improvements, and sustaining changes. Barriers to audits are a lack of resources, expertise, and leadership. Audits aim to improve standards but challenges include support, time constraints, and obtaining consent.
New Clinical Quality Measures and PQRS EHR ReportingPractice Fusion
This presentation will cover how to use Practice Fusion to participate in PQRS using the EHR Reporting Method. Additionally, Practice Fusion supports 27 CQMs, 14 of which were recently released. Each of the new CQMs that Practice Fusion supports will be reviewed in detail.
The document discusses clinical audit, which involves systematically analyzing healthcare quality, procedures, resource use, and patient outcomes and life quality. It describes the clinical audit cycle of defining standards, collecting data on performance, comparing performance to standards, implementing changes if needed, and monitoring additional data. The goals of clinical audits are to improve healthcare quality, efficiency, standards, and patient outcomes and satisfaction. Common methods used in clinical audits include reviewing medical records, incidents of adverse patient reactions, diagnostic investigations, and therapeutic practices. Challenges of auditing primary care include difficulties setting standards, measuring outcomes, accounting for patient views, and causing anxiety for some doctors.
The document discusses performance evaluation of hospitals, which is essential to ensure health services are effective and efficiently using limited resources. It describes evaluating hospitals based on the amount and quality of work, costs, and patient satisfaction. Performance is evaluated through indicators to identify areas for improvement. Methods include indirect analysis of factors influencing care quality and direct analysis of medical records. Clinical audits also evaluate patterns of care quality and resources usage by analyzing topics like diagnostic tests, medical records, and patient satisfaction. The goal is continuously improving patient care and outcomes.
This document discusses key performance indicators (KPIs) and metrics for measuring healthcare operations management. It begins by outlining the objectives and levels of study for the module. It then defines process and outcomes measures that can be used. The document distinguishes between KPIs and the underlying metrics. It provides examples of common clinical and non-clinical metrics in healthcare like average length of stay, patient satisfaction, and operating margin. It also discusses quality metrics used by CMS and principles for effective KPI selection. Overall, the document provides an overview of how performance in healthcare can be measured using metrics and KPIs to enhance organizational performance.
This document discusses key performance indicators (KPIs) and metrics for measuring performance in healthcare organizations. It defines KPIs as measures of performance or outcomes that use clinical and non-clinical metrics. Metrics are the specific numbers or data points used within KPIs to track progress. The document provides examples of common clinical metrics like readmission rates and non-clinical metrics like wait times. It also discusses the importance of measuring performance to manage healthcare operations effectively and outlines standards and requirements for healthcare organization performance measurement.
Similar to Clinical Quality Measures: Measuring and monitoring clinical quality measures in practice fusion (20)
The document discusses key aspects of Meaningful Use Stage 1, including:
1) Eligible providers can qualify for EHR incentive payments through Medicare or Medicaid by meeting Meaningful Use objectives such as recording patient demographics and smoking status for a specified number of patients.
2) There are three stages of Meaningful Use with increasing requirements to improve outcomes, such as engaging patients and improving care coordination.
3) Providers have until February 28th of the following year to attest they met Meaningful Use requirements for an incentive payment for the prior year. Failure to meet requirements could result in penalties under Medicare.
This document provides information about 2015 meaningful use and PQRS reporting requirements. It reviews the attestation process for meaningful use and the different reporting options for PQRS. It also demonstrates how to generate and submit a PQRS file using the Practice Fusion dashboard. Homework assignments are given to review meaningful use resources and set up IACS accounts for PQRS reporting.
An electronic health record (EHR) is a digital version of a patient's paper medical chart. An EHR contains the patient's medical history, diagnoses, medications, allergies, immunizations, lab tests, exams, photos, and more. EHRs allow authorized healthcare providers to securely access a patient's information electronically. This improves care coordination and makes health information instantly available across different healthcare organizations. EHR adoption among US doctors has increased in recent years due to federal incentives that aim to improve patient care through "Meaningful Use" of certified EHR systems.
High blood pressure in the U.S. - City by City Trends 2014Practice Fusion
Practice Fusion analyzed a subset of its 81 million de-identified and aggregated patient health records to understand the percentage of patients with hypertension and the percentage of hypertension patients at goal in 17 major U.S. cities. Practice Fusion also compared those numbers to nationwide blood pressure information from the platform.
Meaningful Use Stage 2 Summary of Care Data Exchange with Practice FusionPractice Fusion
Stage 2 of Meaningful Use requires that providers complete three Summary of Care measures related to sending referrals. Practice Fusion has enabled providers to complete these measures through our new referral workflows.
To learn about how these referral workflows work (including Direct messaging) and how these workflows relate to Meaningful Use, review the slideshow. This detailed guide will walk you through understanding Direct and how to enable it, the variety of ways to send a referral in Practice Fusion, and how to achieve the related Meaningful Use measures.
Physician Quality Reporting System (PQRS) is a CMS reporting program that uses a combination of incentive payments and penalties to promote reporting of quality data. This presentation discusses.
This document provides guidance on attesting for Meaningful Use incentives. It outlines the attestation process, including reporting core and menu measures, clinical quality measures, and documentation requirements. Key deadlines are attending by March 20, 2015 for Medicare and before February 28, 2015 for Medicaid. The document reviews completing attestation on the CMS or state Medicaid website and the steps involved in confirming Meaningful Use achievement.
Learn how to enroll your patients in Practice Fusion's patient portal while meeting all your Meaningful Use Stage 1 and Stage 2 requirements. Our recommended workflow maximizes patient engagement while limiting the burden on your staff.
Understanding the Physician Quality Reporting System (PQRS) Requirements in 2014Practice Fusion
This webinar, Understanding the Physician Quality Reporting System (PQRS) Requirements in 2014, goes over which reporting options are available, what the incentives and penalties are for participating, reporting requirements, and how to choose quality measure for reporting.
The document discusses diagnosis counts. It likely contains data on the number of diagnoses made or recorded. The counts may be broken down by category, location, time period, or other factors important for medical reporting and analysis. In summary, the document title "Diagnosis count" indicates it contains numerical data related to medical diagnoses.
Sectional dentures for microstomia patients.pptxSatvikaPrasad
Microstomia, characterized by an abnormally small oral aperture, presents significant challenges in prosthodontic treatment, including limited access for examination, difficulties in impression making, and challenges with prosthesis insertion and removal. To manage these issues, customized impression techniques using sectional trays and elastomeric materials are employed. Prostheses may be designed in segments or with flexible materials to facilitate handling. Minimally invasive procedures and the use of digital technologies can enhance patient comfort. Education and training for patients on prosthesis care and maintenance are crucial for compliance. Regular follow-up and a multidisciplinary approach, involving collaboration with other specialists, ensure comprehensive care and improved quality of life for microstomia patients.
The Ultimate Guide in Setting Up Market Research System in Health-TechGokul Rangarajan
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
"Market Research it too text-booky, I am in the market for a decade, I am living research book" this is what the founder I met on the event claimed, few of my colleagues rolled their eyes. Its true that one cannot over look the real life experience, but one cannot out beat structured gold mine of market research.
Many 0 to 1 startup founders often overlook market research, but this critical step can make or break a venture, especially in health tech.
But Why do they skip it?
Limited resources—time, money, and manpower—are common culprits.
"In fact, a survey by CB Insights found that 42% of startups fail due to no market need, which is like building a spaceship to Mars only to realise you forgot the fuel."
Sudharsan Srinivasan
Operational Partner Pitchworks VC Studio
Overconfidence in their product’s success leads founders to assume it will naturally find its market, especially in health tech where patient needs, entire system issues and regulatory requirements are as complex as trying to perform brain surgery with a butter knife. Additionally, the pressure to launch quickly and the belief in their own intuition further contribute to this oversight. Yet, thorough market research in health tech could be the key to transforming a startup's vision into a life-saving reality, instead of a medical mishap waiting to happen.
Example of Market Research working
Innovaccer, founded by Abhinav Shashank in 2014, focuses on improving healthcare delivery through data-driven insights and interoperability solutions. Before launching their platform, Innovaccer conducted extensive market research to understand the challenges faced by healthcare organizations and the potential for innovation in healthcare IT.
Identifying Pain Points: Innovaccer surveyed healthcare providers to understand their difficulties with data integration, care coordination, and patient engagement. They found widespread frustration with siloed systems and inefficient workflows.
Competitive Analysis: Analyzed competitors offering similar solutions in healthcare analytics and interoperability. Identified gaps in comprehensive data aggregation, real-time analytics, and actionable insights.
Regulatory Compliance: Ensured their platform complied with HIPAA and other healthcare data privacy regulations. This compliance was crucial to gaining trust from healthcare providers wary of data security issues.
Customer Validation: Conducted pilot programs with several healthcare organizations to validate the platform's effectiveness in improving care outcomes and operational efficiency. Gathered feedback to refine features and user interface.
Ensure the highest quality care for your patients with Cardiac Registry Support's cancer registry services. We support accreditation efforts and quality improvement initiatives, allowing you to benchmark performance and demonstrate adherence to best practices. Confidence starts with data. Partner with Cardiac Registry Support. For more details visit https://cardiacregistrysupport.com/cancer-registry-services/
Health Tech Market Intelligence Prelim Questions -Gokul Rangarajan
The Ultimate Guide to Setting up Market Research in Health Tech part -1
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
This lays foundation of scoping research project what are the
Before embarking on a research project, especially one aimed at scoping and defining parameters like the one described for health tech IT, several crucial considerations should be addressed. Here’s a comprehensive guide covering key aspects to ensure a well-structured and successful research initiative:
1. Define Research Objectives and Scope
Clear Objectives: Define specific goals such as understanding market needs, identifying new opportunities, assessing risks, or refining pricing strategies.
Scope Definition: Clearly outline the boundaries of the research in terms of geographical focus, target demographics (e.g., age, socio-economic status), and industry sectors (e.g., healthcare IT).
3. Review Existing Literature and Resources
Literature Review: Conduct a thorough review of existing research, market reports, and relevant literature to build foundational knowledge.
Gap Analysis: Identify gaps in existing knowledge or areas where further exploration is needed.
4. Select Research Methodology and Tools
Methodological Approach: Choose appropriate research methods such as surveys, interviews, focus groups, or data analytics.
Tools and Resources: Select tools like Google Forms for surveys, analytics platforms (e.g., SimilarWeb, Statista), and expert consultations.
5. Ethical Considerations and Compliance
Ethical Approval: Ensure compliance with ethical guidelines for research involving human subjects.
Data Privacy: Implement measures to protect participant confidentiality and adhere to data protection regulations (e.g., GDPR, HIPAA).
6. Budget and Resource Allocation
Resource Planning: Allocate resources including time, budget, and personnel required for each phase of the research.
Contingency Planning: Anticipate and plan for unforeseen challenges or adjustments to the research plan.
7. Develop Research Instruments
Survey Design: Create well-structured surveys using tools like Google Forms to gather quantitative data.
Interview and Focus Group Guides: Prepare detailed scripts and discussion points for qualitative data collection.
8. Sampling Strategy
Sampling Design: Define the sampling frame, size, and method (e.g., random sampling, stratified sampling) to ensure representation of target demographics.
Participant Recruitment: Plan recruitment strategies to reach and engage the intended participant groups effectively.
9. Data Collection and Analysis Plan
Data Collection: Implement methods for data gathering, ensuring consistency and validity.
Analysis Techniques: Decide on analytical approaches (e.g., statistical
Basics of Electrocardiogram
CONTENTS
●Conduction System of the Heart
●What is ECG or EKG?
●ECG Leads
●Normal waves of ECG.
●Dimensions of ECG.
● Abnormalities of ECG
CONDUCTION SYSTEM OF THE HEART
ECG:
●ECG is a graphic record of the electrical activity of the heart.
●Electrical activity precedes the mechanical activity of the heart.
●Electrical activity has two phases:
Depolarization- contraction of muscle
Repolarization- relaxation of muscle
ECG Leads:
●6 Chest leads
●6 Limb leads
1. Bipolar Limb Leads:
Lead 1- Between right arm(-ve) and left arm(+ve)
Lead 2- Between right arm(-ve) and left leg(+ve)
Lead 3- Between left arm(-ve)
and left leg(+ve)
2. Augmented unipolar Limb Leads:
AvR- Right arm
AvL- Left arm
AvF- Left leg
3.Chest Leads:
V1 : Over 4th intercostal
space near right sternal margin
V2: Over 4th intercostal space near left sternal margin
V3:In between V2 and V4
V4:Over left 5th intercostal space on the mid
clavicular line
V5:Over left 5th intercostal space on the anterior
axillary line
V6:Over left 5th intercostal space on the mid
axillary line.
Normal ECG:
Waves of ECG:
P Wave
•P Wave is a positive wave and the first wave in ECG.
•It is also called as atrial complex.
Cause: Atrial depolarisation
Duration: 0.1 sec
QRS Complex:
•QRS’ complex is also called the initial ventricular complex.
•‘Q’ wave is a small negative wave. It is continued as the tall ‘R’ wave, which is a positive wave.
‘R’ wave is followed by a small negative wave, the ‘S’ wave.
Cause:Ventricular depolarization and atrial repolarization
Duration: 0.08- 0.10 sec
T Wave:
•‘T’ wave is the final ventricular complex and is a positive wave.
Cause:Ventricular repolarization Duration: 0.2 sec
Intervals and Segments of ECG:
P-R Interval:
•‘P-R’ interval is the interval
between the onset of ‘P’wave and onset of ‘Q’ wave.
•‘P-R’ interval cause atrial depolarization and conduction of impulses through AV node.
Duration:0.18 (0.12 to 0.2) sec
Q-T Interval:
•‘Q-T’ interval is the interval between the onset of ‘Q’
wave and the end of ‘T’ wave.
•‘Q-T’ interval indicates the ventricular depolarization
and ventricular repolarization,
i.e. it signifies the
electrical activity in ventricles.
Duration:0.4-0.42sec
S-T Segment:
•‘S-T’ segment is the time interval between the end of ‘S’ wave and the onset of ‘T’ wave.
Duration: 0.08 sec
R-R Interval:
•‘R-R’ interval is the time interval between two consecutive ‘R’ waves.
•It signifies the duration of one cardiac cycle.
Duration: 0.8 sec
Dimension of ECG:
How to find heart rhytm of the heart?
Regular rhytm:
Irregular rhytm:
More than or less than 4
How to find heart rate using ECG?
If heart Rhytm is Regular :
Heart rate =
300/No.of large b/w 2 QRS complex
= 300/4
=75 beats/mins
How to find heart rate using ECG?
If heart Rhytm is irregular:
Heart rate = 10×No.of QRS complex in 6 sec 5large box = 1sec
5×6=30
10×7 = 70 Beats/min
Abnormalities of ECG:
Cardiac Arrythmias:
1.Tachycardia
Heart Rate more than 100 beats/min
Cyclothymia Test: Diagnosing, Symptoms, Treatment, and Impact | The Lifescien...The Lifesciences Magazine
The cyclothymia test is a pivotal tool in the diagnostic process. It helps clinicians assess the presence and severity of symptoms associated with cyclothymia.
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...Media Logic
When it comes to creating marketing strategies that target older adults, it is crucial to have insight into their media habits and preferences. Understanding how older adults consume and use media is key to creating acquisition and retention strategies. We recently conducted our seventh annual survey to gain insight into the media preferences of older adults in 2024. Here are the survey responses and marketing implications that stood out to us.
Malayali Kerala Spa in Ajman, one among the top rated massage centre in ajman, welcomes you to experience high quality massage services from massage staffs from all ove rthe world! Being the best spa massage service providers, we take pride in offering traditional massage services of different countries, like
Indian Massage, Kerala Massage, Thai Massage, Pakistani Massage, Russian Massage etc
If you are seeking relaxation, pain relief, or wellness experience, our ajman spa is here for your unique needs and concerns. The services of our experienced therapists, and personalized attention will ensure that each visit will be memorable for you.
Book your appointment today and let us take you to a world of serenity and self-care. Because you deserves the best.
Satisfying Spa Massage Experience at Just 99 AED - Malayali Kerala Spa AjmanMalayali Kerala Spa Ajman
Our Spa Massage Center Ajman prioritizes efficiency to ensure a satisfying massage experience for our clients at Malayali Kerala Spa Ajman. We offer a hassle-free appointment system, effective health issue identification, and precise massage techniques.
Our Spa in Ajman stands out for its effectiveness in enhancing wellness. Our therapists focus on treating the root cause of issues, providing tailored treatments for each client. We take pride in offering the most satisfying Pakistani Spa service, adjusting treatment plans based on client feedback.
For the most result-oriented Russian Spa treatment in Ajman, visit our Massage Center. Our Russian therapists are skilled in various techniques to address health concerns. Our body-to-body massage is efficient due to individualized care and high-grade massage oils.
The Importance of Black Women Understanding the Chemicals in Their Personal C...bkling
Certain chemicals, such as phthalates and parabens, can disrupt the body's hormones and have significant effects on health. According to data, hormone-related health issues such as uterine fibroids, infertility, early puberty and more aggressive forms of breast and endometrial cancers disproportionately affect Black women. Our guest speaker, Jasmine A. McDonald, PhD, an Assistant Professor in the Department of Epidemiology at Columbia University in New York City, discusses the scientific reasons why Black women should pay attention to specific chemicals in their personal care products, like hair care, and ways to minimize their exposure.
The story of Dr. Ranjit Jagtap's daughters is more than a tale of inherited responsibility; it's a narrative of passion, innovation, and unwavering commitment to a cause greater than oneself. In Poulami and Aditi Jagtap, we see the beautiful continuum of a father's dream and the limitless potential of compassion-driven healthcare.
Test bank clinical nursing skills a concept based approach 4e pearson educati...rightmanforbloodline
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
The facial nerve, also known as cranial nerve VII, is one of the 12 cranial nerves originating from the brain. It's a mixed nerve, meaning it contains both sensory and motor fibres, and it plays a crucial role in controlling various facial muscles, as well as conveying sensory information from the taste buds on the anterior two-thirds of the tongue.
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVedanta A
Air Ambulance Services In Rewa works in close coordination with ground-based emergency services, including local Emergency Medical Services, fire departments, and law enforcement agencies.
More@: https://tinyurl.com/2shrryhx
More@: https://tinyurl.com/5n8h3wp8
2. + How is quality of care measured?
Clinical Quality Measures (CQMs)
+ Quality programs
Encourage reporting of Clinical Quality Measures
How the shift from “Fee for Service” to “Pay for
Performance” is taking place
Pay for Performance
2
Fee for
Service
• Number of
procedures
• Type of
procedures
Pay for
Performance
• Quality of care
• Reduced cost
3. + Clinical Quality Measures consist of two major
components:
Denominator: describes the eligible patient population
for the measure
Numerator: describes the clinical action required by the
measure for reporting and performance
+ Each component of a Clinical Quality Measure is defined
by something called a “measure specification”
+ For Clinical Quality Measures, Practice Fusion has had to
implement the measure according to very specific
guidelines (including how data must be collected and how
the measure is calculated).
+ Providers may not manually calculate CQM values.
Understanding Clinical Quality Measures
3
4. •The population of patients or encounters for which the measure applies.Denominator
•The population of patients from the denominator who meet the measure specified clinical
requirements or the population of encounters from the denominator where the measure
specific requirement has been performed.
Numerator
•Exclusions are specifications that would remove a patient from the denominator of a
specific quality measure. Exceptions do not remove a patient from the denominator.
•Exclusions include certain diagnoses that make it clinically unnecessary for the patient to
receive the numerator clinical action and exceptions include provider or patient determined
reasons for refusing certain clinical actions.
Exclusion/Exception
•This is also known as the EHR reporting period and refers to the time frame for which the
CQMs will be calculated.
Measurement
Period
CQM Terminology
4
5. • The six NQS domains, one of which is assigned to each CMS eCQM, are: Patient
and Family Engagement, Patient Safety,Care Coordination, Population and Public
Health, Efficient Use of Healthcare Resources, and Clinical Processes/Effectiveness.
Consider them the categories that CQMs fall into.
National Quality
Strategy (NQS)
Domains
• NQF reviews, endorses, and recommends use of standardized quality measures.
Not all quality measures are “NQF-endorsed,” but those that are have an assigned
NQF number.
National Quality
Forum (NQF)
• Lists of specific values (terms and their codes) derived from single or multiple
standard vocabularies used to define clinical concepts (e.g. patients with diabetes,
clinical visit, reportable diseases) used in clinical quality measures and to support
effective health information exchange.
Value sets
• An HL7-based standard document format for reporting clinical quality measure
data to CMS for quality improvement programs. Practice Fusion supports QRDA3
file formats, which aggregate data at the population level, and don’t contain
protected patient information.
Quality Reporting
Document
Architecture (QRDA)
CQM Terminology
5
7. CMS
eMeasureID
NQF
number
CQM title NQS domain
CMS2v4 0418 Preventive Care and Screening:
Screening for Clinical Depression and
Follow-Up Plan
Population and Public
Health
CMS22v3 N/A Screening for High Blood Pressure
and Follow-Up Documented
Population/Public Health
CMS50v3 N/A Closing the referral loop: receipt of
specialist report
Care Coordination
CMS68v4 0419 Documentation of Current
Medications in the Medical Record
Patient Safety
CMS69v3 0421 Preventive Care and Screening: Body
Mass Index (BMI) Screening and
Follow-Up
Population and Public
Health
CMS90v4 N/A Functional Status Assessment for
Complex Chronic Conditions
Patient and Family
Engagement
CMS122v3 0059 Diabetes: Hemoglobin A1c Poor
Control
Clinical Process and
Effectiveness
CMS123v3 0056 Diabetes: Foot Exam Clinical Process and
Effectiveness
Practice Fusion Supported CQMs
7
8. CMS
eMeasureID
NQF
number
CQM title NQS domain
CMS124v3 0032 Cervical Cancer Screening Clinical
Processes/Effectiveness
CMS125v3 0031 Breast Cancer Screening Clinical
Processes/Effectiveness
CMS126v3 0036 Use of Appropriate Medications for
Asthma
Clinical
Processes/Effectiveness
CMS127v3 0043 Pneumonia Vaccination Status for
Older Adults
Clinical
Processes/Effectiveness
CMS130v3 0034 Colorectal Cancer Screening Clinical
Processes/Effectiveness
CMS131v3 0055 Diabetes: Eye Exam Clinical
Processes/Effectiveness
CMS138v3 0028 Preventive Care and Screening:
Tobacco Use: Screening and
Cessation Intervention
Population and Public
Health
CMS139v3 0101 Falls: Screening for Future Fall Risk Patient Safety
Practice Fusion Supported CQMs
8
9. CMS
eMeasureID
NQF
number
CQM title NQS domain
CMS144v3 0083 Heart Failure (HF): Beta-Blocker
Therapy for Left Ventricular Systolic
Dysfunction (LVSD)
Clinical
Processes/Effectiveness
CMS147v3 0041 Preventative Care and Screening:
Influenza Immunization
Population/Public Health
CMS149v3 N/A Dementia: Cognitive Assessment Clinical
Processes/Effectiveness
CMS153v3 0033 Chlamydia Screening for Women Clinical
Processes/Effectiveness
CMS155v3 0024 Weight Assessment and Counseling
for Nutrition and Physical Activity for
Children and Adolescents
Population/Public Health
CMS156v3 0022 Use of High-Risk Medications in the
Elderly
Patient Safety
CMS163v3 0064 Diabetes: Low Density Lipoprotein
(LDL) Management
Clinical
Processes/Effectiveness
CMS164v3 0068 Ischemic Vascular Disease (IVD): Use
of Aspirin or Another Antithrombotic
Clinical
Processes/Effectiveness
Practice Fusion Supported CQMs
9
10. CMS
eMeasureID
NQF
number
CQM title NQS domain
CMS165v3 0018 Controlling High Blood Pressure Clinical
Processes/Effectiveness
CMS166v4 0052 Use of Imaging Studies for Low Back
Pain
Efficient Use of
Healthcare Resources
CMS182v3 0075 Ischemic Vascular Disease (IVD):
Complete Lipid Panel and LDL
Control
Clinical
Processes/Effectiveness
Practice Fusion Supported CQMs
10
11. + To support future CQM additions and the entry of structured patient
data in the EHR, Practice Fusion has thousands of searchable and
selectable data elements in the
Screenings/Interventions/Assessments section of the chart note.
Data Elements in Practice Fusion
11
12. + Screenings
+ Assessments
+ Interventions
+ Procedures
+ Diagnostic Studies
+ Documentation of ordered
or delivered follow-up care
What types of data can be recorded in the
Screenings/Interventions/Assessments section?
12
Specialties that the data elements are most
applicable to:
Pediatrics
Primary care
General medicine/Internal medicine
OBGYN
Cardiology
Neurology
13. + Requirement: Report at least 9 CQMs that relate
to at least 3 National Quality Strategy (NQS)
domains:
+ CMS selected 9 recommended CQMs for adult
and pediatric populations
Practice Fusion supports the CMS recommended
CQMs for the adult population
Practice Fusion’s CQMs cover all 6 NQS domains
Meaningful Use CQM Reporting Requirements
Patient and Family Engagement Patient Safety
Care Coordination Population and Public Health
Efficient Use of Healthcare Resources Clinical Processes/Effectiveness
14. CQM Reporting Methods
+ Medicare providers will submit CQMs to CMS electronically or during
Meaningful Use attestation
+ Medicaid providers must submit CQM data to their State Medicaid
Agency
+ Reporting period: Entire calendar year (if submitting electronically) or
90 day reporting period (if submitting during first Meaningful Use
attestation)
+ Electronic submission for 2016: January 1, 2017 – February 28,
2017
Medicare EPs have the option to submit a full year of data electronically to receive
credit for the EHR Incentive Program and the Physician Quality Reporting System
(PQRS) if using the PQRS EHR reporting mechanism.
15. + PQRS Clinical Quality Measures Dashboard
Click on the measure names to get to a detailed knowledge base article
on the CQM
Resources for CQMs
15
17. CMS2v4
Screening for Clinical Depression and Follow-Up Plan
17
Denominator Numerator
All patients aged 12 years and older
before the beginning of the
measurement period with at least one
eligible encounter during the
measurement period.
Patients screened for clinical depression on the
date of the encounter using an age appropriate
standardized tool AND if positive, a follow-up plan
is documented on the date of the positive screen
Practice
Fusion
Suggested
Workflow
Patients who meet the denominator criteria should be screened for
depression using an age-appropriate depression screening
instrument. After conducting the appropriate screening record “Adult
[or Adolescent] depression screening assessment” in the Screenings
/Interventions /Assessments section. If positive, record the
appropriate follow-up plan in the same section.
Examples of data elements that meet the requirements for a follow-
up plan include “Mental health care education (procedure),” “Referral
to psychologist (procedure),” and “Case management follow up
(procedure).”
18. More Measure Details
+ After selecting that the screening
was performed, you must select the
result of depression screening
negative or depression screening
positive.
+ If you are a specialist that doesn’t
conduct depression screenings, you
may see your denominator increase
but not your numerator.
+ This is perfectly acceptable, as the
reporting requirements for
Meaningful Use and PQRS do not
penalize providers for a zero in the
numerator
CMS2v4
Screening for Clinical Depression and Follow-Up Plan
18
1)
2)
19. CMS22v3: Screening for High Blood Pressure and Follow-Up Documented
NQS Domain Population/Public Health
Denominator Numerator
Patients aged 18 and older before
the start of the measurement period.
Patients who were screened for high blood pressure AND have a recommended follow-
up plan documented, as indicated, if the blood pressure is pre-hypertensive or
hypertensive.
Practice Fusion
Suggested
Workflow
After recording the patient’s BP in the chart, determine if the patient is pre-hypertensive or
hypertensive. If so, then record the following in the SIA section of the chart:
• “Follow-up” time-frame (4 weeks, 1 year, etc.). Select that the follow-up was “Ordered” and the
reason as “Finding of hypertension.”
• A blood pressure follow up intervention in the SIA.
Recommended Blood Pressure Follow-Up Interventions
Normal BP: No follow-up required for Systolic BP < 120 mmHg AND Diastolic BP <80 mmHg
Pre-Hypertensive BP: Follow-up with re-screen every year with systolic BP of 120-139 mmHg OR
diastolic BP of 80-89 mmHg AND recommend lifestyle modifications OR referral to Alternative/Primary
Care Provider
First Hypertensive BP Reading: Patients with 1 reading of systolic BP >= 140 mmHg OR diastolic BP
>= 90 mmHg: Follow-up with re-screen > 1 day and < 4 weeks AND recommend lifestyle modifications
OR referral to Alternative/Primary Care Provider
Second Hypertensive BP Reading: Patients with 2nd elevated reading of systolic BP >=140 mmHg OR
diastolic BP >= 90 mmHg: Follow-up with Recommended lifestyle recommendations AND one or more
of the Second Hypertensive Reading Interventions OR referral to Alternative/Primary Care Provider
20. CMS22v3: Screening for High Blood Pressure and Follow-Up Documented
20
Hypertension Screening Ranges
Normal BP Pre-hypertensive BP Hypertensive BP
120/80 mmHg 140/90 mmHg120/80 mmHg - 139/89 mmHg
• Interventions that meet the numerator criteria of this measure include:
• Hypertension education
• Exercise education or exercise counseling
• Target weight discussed
• Dietary management education, guidance and counseling
• Nutrition education
• Referral to a primary care provider can be used as an intervention for this measure, but
this must be recorded in the Screenings/Intervention/Assessments section of the chart
note since “Finding of Hypertension” cannot be selected in the PF referral workflow. If the
referral is used as the intervention for this measure, then a "Follow-up“ is not required.
• Patients who have BP values that are hypertensive (>= 140/90) at two or more visits also
must have one of following recorded:
• Rx for anti-hypertensive pharmacologic therapy,
• A lab order or result for hypertension (CBC with ordered manual differential panel,
urinalysis complete panel, etc.), or
• EKG study or EKG 12 channel panel (recorded under the S/I/A section of the chart)
21. CMS50v3
Closing the referral loop: receipt of specialist report
21
Denominator Numerator
All patients aged 12 years and older
before the beginning of the measurement
period with at least one eligible
encounter during the measurement
period.
Number of patients with a referral, for which the
referring provider received a report from the
provider to whom the patient was referred.
Practice
Fusion
Suggested
Workflow
Referrals that occur in the Practice Fusion referral workflow are tracked in
the referrals of the patient’s timeline. After receiving a follow-up
consultation report from the provider to whom the patient was referred,
select the checkbox next to each completed referral to meet the numerator
criteria.
Referrals that occur outside of Practice Fusion can be recorded by
selecting the appropriate referral data element from the Screenings/
Interventions/Assessments section of the chart note. When a consultation
report has been received from the provider to whom the patient was
referred, this can be logged in a subsequent chart note under the
Screenings/ Interventions/Assessments section by recording
“Confirmatory consultation report (record artifact).”
22. More Measure Details
+ Check the box in the referral tab to indicate that you have
received the follow-up report from the specialist.
+ This measure is primarily targeted to primary care
providers who are referring patients to specialty providers,
however, providers who are specialists who also refer can
track referral loops using this feature and can report this
CQM for Meaningful Use and/or PQRS.
CMS50v3 –
Closing the referral loop: receipt of specialist report
22
23. CMS68v4 –
Documentation of Current Medications in the Medical Record
23
Denominator Numerator
All visits occurring during
the reporting period for
patients aged 18 years and
older before the start of the
measurement period
Eligible professional attests to documenting, updating or
reviewing the patient’s current medications using all
immediate resources available on the date of the encounter.
This list must include ALL known prescriptions, over-the-
counters, herbals and vitamin/mineral/dietary (nutritional)
supplements AND must contain the medications’ name,
dosages, frequency and route of administration
Practice
Fusion
Suggested
Workflow
This measure uses a denominator unit of measurement of all
encounters for patients age 18 and older, which means that the
numerator criteria must be documented for each encounter labeled
“Office Visit” or “Home Visit.” To record your attestation that the
patient’s current medication list is documented in the chart, select
the “Documentation of Current Medications” checkbox under the
Quality of Care section.
24. More Measure Details
+ This measure requires that you attest at each
patient encounter that you have checked the
patient’s current medication list and that it is up to
date.
+ Checking this checkbox not only allows you to
document this attestation for the purposes of
accurate documentation and calculations, it can
also be used if you are ever audited to prove that
you completed this clinical action.
CMS68v4 –
Documentation of Current Medications in the Medical Record
24
25. CMS69v3
Body Mass Index (BMI) Screening and Follow-Up
25
Denominator Numerator
Denominator 1: Patients age 65 and older…
Denominator 2: Patients age 16 through 64 years of
age…
before the beginning of the measurement period with at
least one eligible encounter during the measurement
period NOT INCLUDING encounters where the patient is
receiving palliative care, refuses measurement of height
and/or weight, the patient is in an urgent or emergent
medical situation where time is of the essence and to
delay treatment would jeopardize the patient’s health
status, or there is any other reason documented in the
medical record by the provider explaining why BMI
measurement was not appropriate.
Patients with a documented
BMI during the encounter or
during the previous six months,
AND when the BMI is outside of
normal parameters, a follow-up
plan is documented during the
encounter or during the six
months prior to the encounter
where the BMI was outside of
normal parameters.
26. CMS69v3 –
Body Mass Index (BMI) Screening and Follow-Up
26
Practice
Fusion
Suggested
Workflow
Record height and weight for all patients during eligible encounters
(encounters labeled “Office Visit” or “Home Visit”); Practice Fusion
automatically calculates and records the patient’s BMI. Determine whether the
patient’s BMI falls above or below the normal parameters listed below.
Normal Parameters:
Age 65 years and older BMI ≥ 23 and < 30
Age 18-64 years BMI ≥ 18.5 and < 25
For patients whose BMI falls outside the normal parameters for their age
range, record that an appropriate follow-up plan was either ordered or
performed in the Screenings/ Interventions/Assessments section of the chart
note. After selecting an appropriate follow-up plan, you will need to record the
reason for the follow-up, e.g. “overweight” or “underweight” depending on
where the patient falls in relation to the normal parameters.
Examples of follow-up plans for BMI management include: “Dietary
counseling and surveillance,” “Lifestyle education regarding diet (procedure),”
and “Nutrition therapy (regime/therapy).”
27. More Measure Details
+ After choosing the appropriate counseling or
follow-up plan, you can indicate that it was
ordered or performed.
+ You must also select the appropriate reason
code – overweight or underweight, to receive
credit for this measure.
CMS69v3
Body Mass Index (BMI) Screening and Follow-Up
27
1) 2)
28. CMS90v4
Functional Status Assessment for Complex Chronic Conditions
28
Denominator Numerator
Adults aged 65 years and
older who had two
outpatient encounters
during the measurement
year and an active
diagnosis of heart failure.
Patients with patient reported functional status assessment results
(e.g., VR-12; VR-36; MLHF-Q; KCCQ; PROMIS-10 Global Health,
PROMIS-29) present in the EHR at least two weeks before or
during the initial encounter and the follow-up encounter during the
measurement year.
Practice
Fusion
Suggested
Workflow
This measure requires that patients with heart failure are given functional status
assessments at least twice a year and that the functional status results be
recorded in the EHR at least two weeks before or during the first and follow-up
encounter.
Functional status assessment results can be recorded in the chart note by
searching for and selecting the appropriate functional status assessment result
in the Screenings/ Interventions/Assessments section. Data elements for
functional status assessments can be found by searching for the assessment
name as listed in the numerator description above.
29. More Measure Details
+ Only patients who have at least two encounters (signed chart notes) during the
measurement period (after January 1, 2016) and an active diagnosis of heart failure are
included in the denominator of this measure.
+ To be included in the denominator, the patient’s first encounter must have occurred
sometime before or within 185 days of the start of the measurement period and the
second encounter must be at least 30 days after but no more than 180 days after the
first encounter.
CMS90v4
Functional Status Assessment for Complex Chronic Conditions
29
Encounter A
≤ 185 days from
start of
measurement
period
Encounter B
≥ 30 days and ≤
180 days after
Encounter B
+
Active Diagnosis of Heart Failure
+
and
Denominator Criteria Numerator Criteria
Functional
Status
Assessment
A
≤ 2 weeks
before or
during
Encounter A
Functional
Status
Assessmen
t B
≤ 2 weeks
before or
during
Encounter B
and
30. CMS122v3 – Diabetes: Hemoglobin A1c
Poor Control
30
Denominator Numerator
Patients 18-75 years of age
diabetes with a visit during the
measurement period
Patients whose most recent HbA1c level (performed during
measurement period) is >9.0% or patients who don’t have
A1c test result during the measurement period
Practice Fusion
Suggested Workflow
This measure uses structured lab results that are received or
in the EHR to determine whether a patient falls into the
This is an inverse measure, which means that patients who fall
the numerator do not meet the clinical guidelines.
31. More Measure Details
+ Only structured lab results that include a valid LOINC code
can be used in calculating this measure. Many labs send
us local codes for tests, instead of LOINC – which is
required for the CQM specifications.
+ Practice Fusion is working with our lab partners to map
their local codes to official LOINC codes so that we can
process results more efficiently. If the lab does not
currently send LOINC codes, the provider can manually
enter their lab order and result to receive credit.
+ This is an inverse measure, a high numerator means a
higher number of unhealthy patients
CMS122v3 – Diabetes: Hemoglobin A1c Poor Control
31
32. CMS123v3 – Diabetes: Foot Exam
32
Denominator Numerator
Patients 18-75 years of age
with diabetes with a visit
during the measurement
period
Patients who received visual, pulse and sensory foot
examinations during the measurement period
Practice Fusion
Suggested
Workflow
This measure requires that the patient receive all three of the
foot exams listed in the numerator description. After performing
the required foot exams or confirming that the patient has
received the exams from another medical professional during
the measurement period, search for and record that a “Diabetic
foot exam (visual, sensory, and pulse)” has been performed in
the Screenings/Interventions/Assessments section of the chart
note. This selection is mapped to the coded values for all three
required exams.
33. More Measure Details
+ Instead of adding each exam individually, after
confirming or performing the visual, sensory, and
pulse foot exams, select the option highlighted in
red above to get credit in the numerator.
CMS123v3 – Diabetes: Foot Exam
33
1) 2)
34. CMS124v3: Cervical Cancer Screening
NQS Domain Clinical Processes/Effectiveness
Denominator Numerator
Women 23-64 years of age with a visit
during the measurement period.
Women with one or more Pap tests during the measurement
period or the two years prior to the measurement period.
Practice
Fusion
Suggested
Workflow
Pap test results can be sent to the Practice Fusion EHR by a lab partner or entered in
manually as a lab order and result in the Actions drop down of the patient chart.
The lab test results that meet the numerator criteria for this measure include (but are not
limited to):
• Cytology report of Cervical or vaginal smear or scraping Cyto stain (LOINC 47528-5)
• Cytology report of Cervical or vaginal smear or scraping Cyto stain thin prep (47527-7)
• Cytology Cervical or vaginal smear or scraping study (33717-0)
• Cytology study comment Cervical or vaginal smear or scraping Cyto stain (19774-9)
• Microscopic observation [Identifier] in Cervix by Cyto stain thin prep (18500-9)
• Microscopic observation [Identifier] in Cervix by Cyto stain (10524-7)
35. CMS125v3: Breast Cancer Screening
NQS Domain Clinical Processes/Effectiveness
Denominator Numerator
Women 41–69 years of age with a
visit during the measurement period.
Women with one or more mammograms during the measurement
period or the year prior to the measurement period.
Practice Fusion
Suggested
Workflow
• Breast cancer screenings must be recorded as “Performed” in the
Screenings/Intervention/Assessments section of the new chart note.
• Screenings that are dated during the measurement year or in the year prior
to the measurement year will count towards this measure.
• Screening assessments that meet the numerator of this measure include:
• Screening mammography
• Diagnostic mammography
• Breast mammogram screening
• Right mammogram screening
• Bilateral mammogram screening
• Breast mammogram spot
• Breast mammogram grid
36. CMS125v3: Breast Cancer Screening
36
+ Search for “Breast mammography screening” and
select “Performed.” A result is not required for this
measure and the date of the screening is
defaulted to the date of the chart note unless
otherwise changed by the provider.
37. CMS126v3: Use of Appropriate Medications for Asthma
NQS Domain Clinical Processes/Effectiveness
Denominator Numerator
Patients 5-64 years of age with
persistent asthma and a visit during
the measurement period.
Patients who were dispensed at least one prescription
for a preferred asthma therapy during the
measurement period.
Practice Fusion
Suggested
Workflow
“Persistent Asthma” for the purposes of this CQM must be recorded
by searching for and adding one of the following diagnoses with a
start date on or before the encounter:
• Moderate persistent asthma
• Mild persistent asthma
• Severe persistent asthma
For the moment, providers will not be able to record that a medication
has been dispensed for the purposes of this CQM.
This is a required CQM for Comprehensive Primary Care Initiative –
the vast majority of providers should not select this CQM for reporting
unless absolutely necessary.
38. CMS127v3: Pneumonia Vaccination Status for Older Adults
NQS Domain Clinical Processes/Effectiveness
Denominator Numerator
Patients 65 years of age and
older with a visit during the
measurement period.
Patients who have ever received a pneumococcal
vaccination.
Practice Fusion
Suggested
Workflow
Vaccines (both administered and historical) are entered in Practice
Fusion in the immunizations screen.
• The pneumococcal vaccine can be recorded in the patient chart
under the Immunizations section of the EHR as “administered” or
“historical.”
• Date of vaccine must be before or during the measurement
period to count in the numerator.
• The only pneumococcal vaccines that meet this measure are
Pneumococcal polysaccharide vaccine, 23 valent (CVX 33) and
pneumococcal conjugate vaccine, 13 valent (CVX 133)
39. CMS130v3 – Colorectal Cancer Screening
39
Denominator Numerator
Patients 50-75 years of
age with a visit during
the measurement
period
Patients with one or more screenings for colorectal cancer.
Appropriate screenings are defined by any one of the following
criteria below:
• Fecal occult blood test (FOBT) during the measurement period
• Flexible sigmoidoscopy during the measurement period or the
four years prior to the measurement period
• Colonoscopy during the measurement period or the nine years
prior to the measurement period
Practice
Fusion
Suggested
Workflow
Colorectal cancer screenings can be recorded in the patient chart in the
Screenings/ Interventions/Assessments section or by receiving structured
lab results. Patients are identified as having a visit during the measurement
period if they have a signed chart note labeled with an encounter type of
“office visit.”
To record the colorectal cancer screening, search for the screening that the
patient received and select the appropriate screening. Use the modal to
indicate that the screening was “performed” and the date that the screening
occurred.
40. More Measure Details
+ After selecting the appropriate screening, indicate that it was performed and, if
needed, select the date of performance if it occurred in the past by another
provider.
+ CMS requires an actual lab result with a LOINC code to give numerator credit
for a FOBT test. If your lab partner does not send lab results with LOINC
codes, then you can enter in the lab order and result manually using the
Actions drop down of the patient chart.
CMS130v3 – Colorectal Cancer Screening
40
1) 2)
41. CMS131v3 – Diabetes: Eye Exam
41
Denominator Numerator
Patients 18-75 years of age
with diabetes with a visit
during the measurement
period
Patients with an eye screening for diabetic retinal disease.
This includes diabetics who had one of the following:
• A retinal or dilated eye exam by an eye care
professional in the measurement period, or
• A negative retinal exam (no evidence of retinopathy) by
an eye care professional in the year prior to the
measurement period.
Practice Fusion
Suggested
Workflow
After performing the required exam or confirming that the
patient has received the exam from an eye care professional,
search for and record that an “Examination of the retina
(procedure)” has been performed in the
Screenings/Interventions/Assessments section of the
encounter.
42. More Measure Details
+ For this measure, the patient must have received the eye
exam from an eligible eye professional.
+ After determining that the patient has had this exam from a
eligible eye professional, search and choose the
applicable exam, indicate that it was performed and on
what date, and if you choose, include a note about the
provider in the comments section.
CMS131v3 – Diabetes: Eye Exam
42
43. CMS138v3
Tobacco Use: Screening and Cessation Intervention
43
Denominator Numerator
All patients aged 18 years and
older
Patients who were screened for tobacco use at least
once within 24 months AND who received tobacco
cessation counseling intervention if identified as a
tobacco user.
Practice Fusion
Suggested
Workflow
Record a smoking status in theSocial historysection Summary
tab or chart note for all patients and if the patient’s smoking
status indicates they are a tobacco user, document a tobacco
cessation counseling intervention in the
Screenings/Assessments/Interventions section of the chart
note.
44. More Measure Details
+ Examples of smoking cessation interventions that you can
choose are “smoking cessation education (procedure)” or
“referral to stop smoking clinic (procedure)”
+ The smoking cessation intervention that is added to the
chart can be “performed” or “ordered” and a result is not
needed to receive credit for this measure.
CMS138v3–Tobacco Use: Screening and Cessation Intervention
44
1) 2)
45. CMS139v3: Falls: Screening for Future Fall Risk
NQS Domain Patient Safety
Denominator Numerator
Patients aged 65 years and older with
a visit during the measurement period.
Patients who were screened for future fall risk at
least once within the measurement period.
Practice
Fusion
Suggested
Workflow
• Future fall risk: Patients are considered at risk for future falls if they have
had 2 or more falls in the past year or any fall with injury in the past year.
• Search for “Falls Risk Assessment” in the
Screenings/Interventions/Assessments section of the chart note and
indicate that it has been “performed.”
• The start date defaults to the date of the chart note but can be
backdated if needed.
• A result is not needed for the Falls Risk Assessment.
46. CMS139v3: Falls: Screening for Future Fall Risk
46
+ Search and record “Falls Risk Assessment” as “Performed” in the
Screenings/Interventions/Assessments section of the chart note.
+ A result is not needed and the start date is defaulted to the date of the encounter. An
end date is not needed for this CQM.
47. CMS144v3 Heart Failure (HF):
Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
NQS Domain Clinical Processes/Effectiveness
Denominator Numerator
All patients aged 18 years and older with at least two encounters during the
measurement period, AND:
1) A Dx of heart failure, AND
2) One of the following:
• LVEF result that is <40%, OR
• A Dx of moderate or severe LVSD,
That occurs before or during the second encounter for the patient during the
measurement year.
Patients who were prescribed beta-
blocker therapy within a 12 month
period when seen in the outpatient
setting.
Practice
Fusion
Suggested
Workflow
• Patient is added to the measure denominator after their 2nd encounter of the measurement period.
• Beta-blockers that meet the numerator criteria for this measure include (but are not limited to):
• 24 HR Hydrochlorothiazide 12.5 MG / Metoprolol Tartrate 50 MG Extended Release Tablet
• 24 HR Metoprolol Tartrate 50 MG Extended Release Tablet (other dosages qualify as well)
• 24 HR carvedilol phosphate 80 MG Extended Release Capsule (other dosages qualify as well)
• Bisoprolol Fumarate 5 MG / Hydrochlorothiazide 6.25 MG Oral Tablet (other dosages qualify as
well)
• Carvedilol 25 MG Oral Tablet (other dosages qualify as well)
48. 48
+ Providers should ensure patients are prescribed or have an active medication for beta-blockers at any
encounter in which the patient meets the denominator criteria for this measure:
A Dx of heart failure, AND
One of the following:
1) LVEF result that is <40%, OR
2) A Dx of moderate or severe LVSD
+ LVEF results must be entered as structured lab results in Practice Fusion.
This signifies that a LOINC code must be attached to the lab result. If the lab partner does not send LOINC codes, the
lab order and result can be manually entered from the Actions drop down.
+ This CQM does not have any denominator exclusions, but the following represent exceptions:
Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, low blood pressure, fluid overload,
asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical
reasons)
Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient
reasons)
Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the
healthcare system)
CMS144v3 Heart Failure (HF):
Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
49. CMS147v3: Preventative Care and Screening: Influenza Immunization
NQS Domain Population/Public Health
Denominator Numerator
All patients aged 6 months and older with at least two encounters
during the measurement period and one encounter that occurred
between October 1st of the previous measurement period and
March 31st of the current measurement period.
Patients who received an influenza
immunization OR who reported
previous receipt of an influenza
immunization
Practice
Fusion
Suggested
Workflow
• This measure is looking to see whether patients received the influenza vaccine during a
single flu season that occurs between October 1st of the previous year and March 31st of
the current year.
• Influenza vaccines that meet this measure include:
• Influenza, seasonal injectable (CVX 141)
• Influenza seasonal, injectable, preservative free (CVX 140)
• Influenza, high dose seasonal, preservative-free (CVX 135)
• Influenza, live, intranasal, quadrivalent (CVX 149)
• Seasonal influenza, intradermal, preservative free (CVX 144)
• Influenza, injectable, quadrivalent, preservative free (CVX 150)
• Influenza virus vaccine, live, attenuated, for intranasal use (CVX 111)
50. CMS147v3: Preventative Care and Screening: Influenza Immunization
50
+ Previous receipt of influenza (such as a patient who received the vaccine at work) can
be recorded:
In the Screenings/Intervention/Assessments section of the chart note by searching for
“Has influenza vaccination at…” or
By recording a “historical” vaccine in the immunization section of the EHR and
including a date between October 1st - March 31st
+ To enable reporting of this measure at the close of the reporting period, this measure
will only assess the influenza season that ends in March of the reporting period. The
subsequent influenza season (ending March of the following year) will be measured and
reported in the following year.
51. CMS149v3: Dementia: Cognitive Assessment
NQS Domain Clinical Processes/Effectiveness
Denominator Numerator
All patients, regardless of age, with a
diagnosis of dementia and at least two
encounters during the measurement period.
Patients for whom an assessment of cognition is
performed and the results reviewed at least once within a
12 month period.
Practice
Fusion
Suggested
Workflow
Cognitive assessments are conducted outside of the EHR but can be recorded in the
patient chart under Screenings/Intervention/Assessments. Standardized assessments that
meet this CQM criteria include:
• Total score BOMC
• Total score MoCA
• Total score MMSE
• Total score AD8
• Total score IQCODE
• Total score SLUMS
• Prior assessment brief interview for mental status (BIMS) summary score MDSv3
52. CMS149v3: Dementia: Cognitive Assessment
52
+ Patients will be added to the denominator of this measure in the CQM report after their
2nd encounter.
+ The cognitive assessment should be conducted and recorded during the 1st encounter
during the measurement period and reviewed during the 2nd encounter of the
measurement period
However, this CQM will give credit if the assessment is recorded during any
encounter during the measurement year (since review of the assessment is not
measured as part of this CQM).
+ Use of a standardized tool or instrument to assess cognition other than those listed in
the previous table will still meet numerator performance.
Search and record the data element “Assessment and interpretation of higher
cerebral function, cognitive testing” if you use an assessment tool not otherwise
listed.
53. CMS153v3: Chlamydia Screening for Women
NQS Domain Population/Public Health
Denominator Numerator
Women 16 to 24 years of age who are sexually active and
who had a visit in the measurement period.
Women with at least one chlamydia test
during the measurement period.
Practice
Fusion
Suggested
Workflow
Codes to identify sexually active women include codes for:
• pregnancy
• sexually transmitted infections
• contraceptives
• contraceptive devices
• infertility treatments
54. CMS153v3: Chlamydia Screening for Women
54
+ The U.S. Preventive Service Task Force recommends that sexually active non-
pregnant young women age 24 years or younger and older women (pregnant or
not) who are at increased risk should be screened for a chlamydial infection.
+ Chlamydia test results must come through structured lab results into the EHR.
This signifies that a LOINC code must be attached to the lab result. If the lab partner does
not send LOINC codes, the lab order and result can be manually entered from the Actions
drop down.
55. CMS155v3: Weight Assessment and Counseling
for Nutrition and Physical Activity for Children and Adolescents
NQS Domain Population/Public Health
Denominator Numerator
Patients 3-17 years of age with at
least one outpatient visit with a
primary care physician (PCP) or an
obstetrician/gynecologist (OB/GYN)
during the measurement period.
Numerator 1: Patients who had a height, weight and body mass
index (BMI) percentile recorded during the measurement period
Numerator 2: Patients who had counseling for nutrition during the
measurement period
Numerator 3: Patients who had counseling for physical activity
during the measurement period
Practice
Fusion
Suggested
Workflow
• BMI percentile is automatically calculated for patients in this age range who have height
and weight recorded
• Counseling for nutrition and physical activity are recorded under the
Screenings/Intervention/Assessments section
• Examples of interventions for counseling for nutrition (numerator 2) include: “nutrition education,”
“lifestyle education regarding diet,” and “weight control education.”
• Examples of interventions for counseling for physical activity (numerator 3) include: “exercise
education,” “patient advised about exercise,” and “recommendation to exercise.”
56. 56
+ To meet Numerator 1, providers must record the height and weight during the
measurement period.
+ Numerator 2 includes all of the requirements of Numerator 1 + recording an
intervention of counseling for nutrition.
+ Numerator 3 includes all of the requirements of Numerator 1 + Numerator 2 +
recording an intervention for counseling for physical activity.
CMS155v3: Weight Assessment and Counseling
for Nutrition and Physical Activity for Children and Adolescents
57. CMS156v3– Use of High-Risk Medications in the Elderly
57
Denominator Numerator
Patients 66 years and older who had
a visit during the measurement period
Numerator 1: Patients with an order for at least one
high-risk medication during the measurement
period.
Numerator 2: Patients with an order for at least two
different high-risk medications during the
measurement period.
Practice Fusion
Suggested
Workflow
“High-risk” medications are those that can result in adverse
events or medications that are clinically inappropriate for
seniors. This measure is calculated based on the medications
that prescribed to patients who meet the denominator criteria.
Patients are identified as having a visit during the measurement
period if they have a signed chart note labeled with an
encounter type of “office visit,” "home visit," "nurse visit," or
"nursing home visit."
58. More Measure Details
+ Examples of high risk medications as defined by this measure include certain
dosages and strengths of:
Acetaminophen
Butabarbital sodium
Diphenhydramine Hydrochloride
Estrogens
+ Go to www.ushik.org to download the “High risk medications for the elderly” Value
Set to see the full list.
CMS156v3– Use of High-Risk Medications in the Elderly
58
59. CMS163v3: Diabetes: Low Density Lipoprotein (LDL) Management
NQS Domain Clinical Processes/Effectiveness
Denominator Numerator
Patients 18-75 years of age with diabetes
with a visit during the measurement
period.
Patients whose most recent LDL-C level
performed during the measurement period is
<100 mg/dL.
Practice
Fusion
Suggested
Workflow
The LDL-C test results that meet the numerator criteria for this measure
include:
• Cholesterol in LDL [Mass/volume] in Serum or Plasma (LOINC 2089-1)
• Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay
(LOINC 18262-6)
• Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation
(LOINC 13457-7)
60. CMS163v3: Diabetes: Low Density Lipoprotein (LDL) Management
60
+ This measure will look for the most recent (e.g. the last recorded) LDL-C result
in the EHR that occurred during the measurement period for the purposes of
the numerator criteria.
+ LDL test results must come through structured lab results into the EHR.
This signifies that a LOINC code must be attached to the lab result. If the lab partner does not
send LOINC codes, the lab order and result can be manually entered from the Actions drop down.
+ Patients with a diagnosis of gestational diabetes are excluded from this
measure.
61. NQS Domain Clinical Processes/Effectiveness
Denominator Numerator
Patients 18 years of age and older with a visit
during the measurement period, and an
active diagnosis of ischemic vascular disease
(IVD) during the measurement period.
Patients who have documentation of use of
aspirin or another antithrombotic during the
measurement period.
Practice
Fusion
Suggested
Workflow
Medications that meet the numerator criteria for this measure include the
following:
• Prasurgrel (5mg and 10mg oral tablet)
• Aspirin (varying dosages and tablet types, for example: 81 mg chewable
tablet, 80 mg oral tablet, 228 mg chewing gum, 300 mg oral capsule, 162
mg enteric coated tablet, etc.)
• Clopidogrel (300mg and 75 mg oral tablet)
CMS164v3: Ischemic Vascular Disease (IVD):
Use of Aspirin or Another Antithrombotic
62. CMS164v3: Ischemic Vascular Disease (IVD):
Use of Aspirin or Another Antithrombotic
62
+ Diagnoses must include a start date and the end date cannot be before
the measurement period to qualify the patient for the denominator.
The Dx start date does not need to be during the measurement year.
+ Prescriptions and medications added to the patient’s medication list that
will qualify the patient for the numerator.
A start date must be recorded for these medications to be included in
CQM calculations (but the start date does not need to be during the
measurement year).
Medications and prescriptions cannot have a stop date prior to the
measurement period.
63. CMS 165v3 – Controlling High Blood Pressure
63
Denominator Numerator
Patients 18-85 years of age who
had a diagnosis of essential
hypertension within the first six
months of the measurement period
or any time prior to the
measurement period
Patients whose blood pressure at the
most recent visit is adequately
controlled (systolic blood pressure <
140 mmHg and diastolic blood
pressure < 90 mmHg) during the
measurement period.
Practice Fusion
Suggested
Workflow
Record blood pressure in the chart note for all
patients who have a diagnosis for hypertension
during each encounter. Patients whose blood
pressure is uncontrolled should be monitored and
have their vital signs updated at each follow-up visit.
64. CQM Measurement Period
More Measure Details
+ This timeline is helpful for understanding how this measure looks at
hypertension diagnosis and blood pressure.
+ Please note that this CQM is not intended to encompass all potential
hypertensive patients, but rather this measure is looking specifically to see
that providers can control the blood pressure of their hypertensive patients
within the first 6 months of diagnosis.
CMS 165v3 – Controlling High Blood Pressure
64
1/1/2014 12/31/20146/1/2014
Patients diagnosed with hypertension prior to the start of the measurement period whose hypertension is
resolved before the start of the measurement period ARE NOT included in the denominator.
Patients diagnosed with hypertension prior to the start of the measurement period whose hypertension is
still ACTIVE after the start of the measurement period ARE included in the denominator, if they have an
encounter during the measurement period.
All patients who are diagnosed with hypertension within the first 6 months of the measurement period and
have an encounter during that time ARE included in the denominator.
All patients with an active diagnoses for hypertension who have an encounter during the measurement
period ARE included in the denominator of the measure.
65. CMS166v4 – Use of Imaging Studies for Low Back Pain
65
Denominator Numerator
Patients 18-50 years of age with a
diagnosis of low back pain during
an outpatient or emergency
department visit
Patients without an imaging study conducted on the
date of the outpatient or emergency department visit
or in the 28 days following the outpatient or
emergency department visit
Practice
Fusion
Suggested
Workflow
The numerator value for this measure is determined after a 28 day
period following each relevant encounter. Practice Fusion only uses
encounters that are labeled with “Office Visit” in the denominator of
this measure.
Imaging studies that have been performed should be recorded in the
Screenings/ Interventions/Assessments section of the chart note.
Practice Fusion will also use imaging results that are sent to or
entered into the EHR manually for the purposes of calculating this
measure.
66. More Measure Details
+ This measure looks to see if providers are avoiding
unnecessary imaging tests for patients with low back pain.
+ Examples of eligible diagnoses for “low back pain” include:
Sciatica, unspecified side
Low back pain
Lumbago
Backache, unspecified
+ Because this measure is looking to see whether an
imaging test is performed within 28 days of diagnosis, you
will not see any values for this numerator until at least 29
days after the encounter where the patient was diagnosed.
CMS166v4 – Use of Imaging Studies for Low Back Pain
66
67. CMS182v3: Ischemic Vascular Disease (IVD):
Complete Lipid Panel and LDL Control
NQS Domain Clinical Processes/Effectiveness
Denominator Numerator
Patients 18 years of age and older with a visit
during the measurement period, and an active
diagnosis of ischemic vascular disease (IVD)
during the measurement period.
Numerator 1: Patients with a complete lipid profile
performed during the measurement period
Numerator 2: Patients whose most recent LDL-C level
performed during the measurement period is <100 mg/dL
Practice
Fusion
Suggested
Workflow
This measure requires recorded lab results in the EHR. The following lab results meet
the criteria for Numerator 1 of this CQM:
• Lipid panel with direct LDL - Serum or Plasma (LOINC 57698-3), OR
• Lipid 1996 panel - Serum or Plasma (LOINC 24331-1), OR
• ALL of the following together during the measurement period:
• Total cholesterol Laboratory test (LOINC 2093-3)
• HDL-C Laboratory test (LOINC 2085-9)
• LDL-C Laboratory Test (LOINC 13457-7, 18262-6, or 2089-1)
• Triglycerides Laboratory test (LOINC 12951-0 or 2571-8)
68. CMS182v4: Ischemic Vascular Disease (IVD):
Complete Lipid Panel and LDL Control
68
+ Lipid Panels and LDL test results must come through structured lab results
into the EHR.
This signifies that a LOINC code must be attached to the lab result. If the lab partner
does not send LOINC codes, the lab order and result can be manually entered from
the Actions drop down.
Editor's Notes
Patients who meet the denominator criteria should be screened for depression using an age-appropriate depression screening instrument. After conducting the appropriate screening record “Adult [or Adolescent] depression screening assessment” in the Screenings /Interventions /Assessments section. If positive, record the appropriate follow-up plan in the same section.
Examples of data elements that meet the requirements for a follow-up plan include “Mental health care education (procedure),” “Referral to psychologist (procedure),” and “Case management follow up (procedure).”
Bug right now for recording
More Measure Details
This measure requires that you attest at each patient encounter that you have checked the patient’s current medication list and that it is up to date.
Checking this checkbox not only allows you to document this attestation for the purposes of accurate documentation and calculations, it can also be used if you are ever audited to prove that you completed this clinical action.
Practice Fusion automatically calculations BMI for patients how have height and weight recorded in the EHR. Note that only BMIs that are less than 6 months old (meaning the patient had an encounter where height and weight were recorded sometime in the past 6 months) are eligible for numerator credit in this measure.
Must document the follow-up plan, either ordered or performed, and then provide a REASON for why the follow-up plan is being recorded. This reason will be either because the BMI falls above the normal parameters or because the BMI falls below the normal parameters. This information is entered in the Screenings/Assessments/Interventions section after the appropriate follow-up plan is selected.
More Measure Details
The data element “Diabetic foot exam (visual, sensory, and pulse)” has been mapped to the coded values for all three exams required for this measure.
Instead of adding each exam individually, after confirming or performing the visual, sensory, and pulse foot exams, select the option highlighted in green above to get credit in the numerator.
Colorectal cancer screenings can be recorded in the patient chart in the Screenings/ Interventions/Assessments section or by receiving structured lab results. Patients are identified as having a visit during the measurement period if they have a signed chart note labeled with an encounter type of “office visit.”
To record the colorectal cancer screening, search for the screening that the patient received and select the appropriate screening. Use the modal to indicate that the screening was “performed” and the date that the screening occurred.
For patients given a Fecal Occult Blood Test (FOBT), they will be included in the numerator once a structured lab result is received in the EHR. Only screenings that occur during the appropriate timeframe listed in the numerator description will receive numerator credit for this measure.
To record the colorectal cancer screening, search for the screening that the patient received and select the appropriate screening. Use the modal to indicate that the screening was “performed” and the date that the screening occurred. For patients given a Fecal Occult Blood Test (FOBT), they will be included in the numerator once a structured lab result is received in the EHR. Only screenings that occur during the appropriate timeframe listed in the numerator description will receive numerator credit for this measure.
CMS has created the 2014 electronic clinical quality measures (eCQMs) to have more rigorous data collection requirements than previous Meaningful Use quality measures. As such, there are some limitations in how Practice Fusion can collect data for purposes of CQM calculations and reporting. An example of this is that CMS requires an actual lab result when a measure requires a performed FOBT test (or result). While we are working with our lab partners to increase how many send structured LOINC codes to identify these tests, we are also working with those lab partners to map and identify test results that come in with local laboratory codes so that we can properly give credit when we are able to.
More Measure Details
For this measure, the patient must have received the eye exam from an eligible eye professional.
After determining that the patient has had this exam from a eligible eye professional, search and choose the applicable exam, indicate that it was performed and on what date, and if you choose, include a note about the provider in the comments section.
More Measure Details
Examples of smoking cessation interventions that you can choose are “smoking cessation education (procedure)” or “referral to stop smoking clinic (procedure)”
The smoking cessation intervention that is added to the chart can be “performed” or “ordered” and a result is not needed to receive credit for this measure.
LVEF result would need to be recorded via manual lab result entry.
Put in some examples of high-risk medications.
Diagnosis of hypertension must occur at least 6 months prior to the uncontrolled blood pressure. Providers should not be “dinged” for uncontrolled BP that occurs immediately the diagnosis of hypertension.
More Measure Details
This measure looks to see if providers are avoiding unnecessary imaging tests for patients with low back pain.
Examples of eligible diagnoses for “low back pain” include:
Sciatica, unspecified side
Low back pain
Lumbago
Backache, unspecified
Because this measure is looking to see whether an imaging test is performed within 28 days of diagnosis, you will not see any values for this numerator until at least 29 days after the encounter where the patient was diagnosed.